Navigation Links
Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75
Date:11/3/2009

Specialty Pharmacy Group

Revenues for Accredo Health Group grew 19.2 percent to a record of over $2.4 billion, compared to $2.0 billion in the third quarter of 2008, reflecting the contribution from significant new client wins and continued growth across the specialty business.

Accredo's gross margin was 7.4 percent in the third quarter of 2009 compared to 8.1 percent for the same period in 2008, reflecting channel mix. Accredo achieved operating income growth of 19.5 percent, earning a record $93.2 million in the quarter, up from $78.0 million in the third quarter of 2008.

Share Repurchase Program

As part of its $3 billion share repurchase program, through September year-to-date, Medco repurchased 23.6 million shares at a total cost of $1.01 billion with an average per share cost of $42.71. These repurchases took place in the first and second quarters of 2009, with no shares repurchased in the third quarter. Since the inception of the current program in November 2008, Medco has repurchased 28.7 million shares for a total cost of $1.21 billion with an average per-share cost of $42.01.

Guidance

Medco raised and narrowed its full-year 2009 GAAP diluted EPS guidance to a range of $2.58 to $2.60, representing 21 to 22 percent growth over 2008. Previous GAAP diluted EPS guidance, which was raised and narrowed as of the second quarter 2009, reflected a range of $2.54 to $2.59 and 19 to 22 percent growth over 2008.

Excluding amortization of intangible assets, diluted EPS was raised and narrowed to a range of $2.80 to $2.82, representing 20 to 21 percent growth over 2008. Previous diluted EPS guidance, which was raised and narrowed as of the second quarter 2009, reflected a range of $2.76 to $2.81 and 18 to 21 percent growth over 2008.

For the full-year 2010, Medco expects to achieve GAAP diluted EPS in the range of $3.05 to $3.15, representing grow
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Medco to Present at November 2009 Investor Conferences
2. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
3. Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs
4. Medco Announces Date for Third-Quarter 2009 Financial Results; Company to Provide 2010 Earnings Guidance
5. Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children
6. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
7. Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
8. Hoviones TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
9. Vtech(R) Delivers Todays Hottest Trends to Tech-Savvy Kids
10. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
11. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., Mass., Nov. 30 According to Mill...on medical technology market intelligence, the nea...eclined by almost 5% over 2008 as patients chose t...nomic crisis. The market will, however, begin reco...ng pre-recession growth rates of over 15%. MRG,s f...
(Date:11/30/2009)...Nov. 30 Minimally-invasive procedu...rgery, particularly in oncology, cardiology and wo...or image-guided navigation expected to reach $600 ...ntages offered by minimally-invasive procedures, i...atient comfort and faster patient throughput. ,...
(Date:11/30/2009)..., Mass., Nov. 30 Decision Resource...y firms focusing on pharmaceutical and healthcare ...market in Russia will grow nine percent annually o...llion by 2013. This growth will be driven mainly b...increased use of more-expensive therapies like peg...
Breaking Medicine Technology:Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3Relieving pain affecting millions 57450 1Relieving pain affecting millions 57450 2Relieving pain affecting millions 57450 3VA Secretary to Help Launch The Red Sox Foundation Massachusetts General Hospital Home Base Program 57448 1VA Secretary to Help Launch The Red Sox Foundation Massachusetts General Hospital Home Base Program 57448 2InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture 57446 1InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture 57446 2
... Oct. 22 Peregrine,Pharmaceuticals, Inc. (Nasdaq:...ny developing monoclonal antibodies for the treatm...n, today announced that it has submitted a,Phase I... the Republic of,Georgia to study bavituximab in c... patients with metastatic breast cancer. The open ...
... to Move Compound Forward into Phase III - - Con...tern Time -, LA JOLLA, Calif., Oct. 22 TorreyPin...nced that tezampanel met the,primary endpoint in a...atment of a single, acute migraine attack. In the ...cutaneously, the 40 mg dose demonstrated,statistic...
Other Medicine Technology:Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 4Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 2Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 3Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 4Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 5Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 6Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 7Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 8
(Date:11/30/2009)...Newswire/ -- HealthPlus of Michigan today announce...plans designed for Medicare-eligible people lookin...cess to quality health care. ,, HealthPlus Med...in Michigan, according to the "America,s Best Heal...& World Report and the National Committee on Q...
(Date:11/30/2009)...ewswire-USNewswire/ -- At a briefing of the Leader... Consortium for Citizens with Disabilities (CCD) t...cy and Advocacy for NCOA, called on Congress to en...to the growing crisis in long-term care for older ...eniors, after working hard all their lives, are be...
(Date:11/30/2009)...far from over. Every year, almost three million p...e from AIDS-related diseases." ,, WASHINGTON, ...ay 2009 the Global AIDS Alliance (GAA) calls on Pr...ecent alarming reports from the World Health Organ...nues to be of catastrophic proportion, affecting s...
(Date:11/30/2009)...ficant impact, CBO analysis understates the effect.../ -- The Blue Cross and Blue Shield Association ...he estimate released today by the Congressional Bu...hat many economists, actuaries, and health policy ... reform bill would make coverage more expensive fo...
(Date:11/30/2009)...alent to 113 chest X-rays, study finds , ...alf of patients who have abdominal/pelvic CT scans... expose them to extra radiation, U.S. researchers ...c series were performed on 500 patients aged 9 mon...0 years of age. The researchers concluded that 35....
Breaking Medicine News(10 mins):Health News:HealthPlus Launches New Medicare Advantage Plans 2Health News:HealthPlus Launches New Medicare Advantage Plans 3Health News:NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:CT Scan Patients May Get Unnecessary Imaging 2
...mpanies Glenmark pharma and Nicholas Piramal has w...ket after USFDA ban the sale of Valdecoxib formula...y // the health ministry of the government of Indi... of the National Pharmacological vigilance Advisor...
...s only tiny gadgets that have changed the lives of...have developed a small device resembling a MP3 pla...ance // disorder, by giving the wearer's brain mor... result of ototoxicity, can affect people of all a...
...ting plenty of fish have been seen in a wealth of ...ort study has led to a surprising observation – th...eventual death from stroke. // Fish Oil is o... even pointed to improved behavior of children wit...
... latest online edition of The Lancet Neurology say...nce of having multiple sclerosis is nothing but a ...e their risk of having the disease, nor does their...n MS. Previous research has reported a higher risk...
...f scientists to create stem cells that resemble th...ramming to the embryonic state could eliminate the...s for the same. // If future experiments are...the hybrid cells could theoretically be used to pr...
...more harm than what you think. Low doses of radiat...ent in children. It is not uncommon for childre...iation therapy // . The fact that this could resul...e greatest rates of decline in IQ and reading skil...
Other Medicine News:Health News:A Latest Study Links Fish To Stroke 2
...em, developed by Given Imaging of Israel, is a min.... Weighing in at only four grams, it contains a mi...and radio transmitter coated by a smooth biocompat...s. Internal gastric images are transmitted to a wa...
...f the innovative EUS EXERA system from Olympus is ...ce to meet all of your observation and diagnosis n...strovideoscope, the EU-M60 allows for increased de...dy and greater resolution allowing you to focus on...
..., highly accurate & lightweight system utilizing s...ity that can take extensive measurements over a 24...intervals from 5 to 60 minutes. Powerful Microsof...ata collection and analysis. Easy to configure & ...
Total T3 EIA Thyroid Function 025-BC-1005
Medicine Products: